Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7799 USD | -3.36% | -3.00% | +36.82% |
May. 14 | Viracta Therapeutics Appoints Michael Faerm CFO | MT |
May. 14 | Viracta Therapeutics, Inc. Appoints Michael Faerm as Chief Financial Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.82% | 31.69M | |
+40.97% | 54.04B | |
+43.57% | 41.96B | |
-1.21% | 41.92B | |
-7.59% | 28.35B | |
+12.45% | 26.35B | |
-22.11% | 19B | |
+7.81% | 13B | |
+28.48% | 12.28B | |
+24.64% | 12.19B |
- Stock Market
- Equities
- VIRX Stock
- News Viracta Therapeutics, Inc.
- Viracta Therapeutics, Inc. Announces Board Changes